China Approves Inhaled Covid Vaccine

The video discusses the development and challenges of inhaled COVID-19 vaccines, highlighting the benefits of mucosal immunization in preventing virus transmission. It compares the efficacy of inhaled vaccines to injectable ones and explores the development of mRNA vaccines. The video also touches on Cansino's market position and its diverse vaccine pipeline.

How does mucosal immunization help in preventing the transmission of airborne diseases?

What are the challenges faced in developing the inhaled COVID-19 vaccine?

What is the efficacy of the injectable vaccine mentioned in the text?

What are the immune responses measured in the clinical trials for the inhaled vaccine?

What is the significance of the mucosal immune response in the context of the vaccine?

What is the current status of the MMR vaccine in terms of clinical trials?

How does the company plan to address the challenges in the current vaccination program?